Moving forward with breast cancer preven
โ
Wendy Y. Chen; Bernard Rosner; Graham A. Colditz
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 75 KB
Despite randomized controlled trial data supporting the use of selective estrogen receptor modulators (SERMs) to reduce the incidence of breast cancer, to the authors' knowledge uptake has been limited. Similar to cardiovascular risk models, the routine use of breast cancer risk prevention models in